Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480–489 (2011).
Google Scholar
Rosenberg, S. A. Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know. Nat. Rev. Clin. Oncol. 8, 577–585 (2011).
Google Scholar
Gong, N., Sheppard, N. C., Billingsley, M. M., June, C. H. & Mitchell, M. J. Nanomaterials for T-cell cancer immunotherapy. Nat. Nanotechnol. 16, 25–36 (2021).
Google Scholar
Huang, X. et al. DNA scaffolds enable efficient and tunable functionalization of biomaterials for immune cell modulation. Nat. Nanotechnol. 16, 214–223 (2021).
Google Scholar
Andersen, R. et al. Long-lasting complete responses in patients with metastatic melanoma after adoptive cell therapy with tumour-infiltrating lymphocytes and an attenuated IL2 regimen. Clin. Cancer Res. 22, 3734–3745 (2016).
Google Scholar
Dudley, M. E. Cancer regression and autoimmunity in patients after clonal repopulation with antitumour lymphocytes. Science 298, 850–854 (2002).
Google Scholar
Rosenberg, S., Spiess, P. & Lafreniere, R. A new approach to the adoptive immunotherapy of cancer with tumour-infiltrating lymphocytes. Science 233, 1318–1321 (1986).
Google Scholar
Yamamoto, T. N., Kishton, R. J. & Restifo, N. P. Developing neoantigen-targeted T cell–based treatments for solid tumours. Nat. Med. 25, 1488–1499 (2019).
Google Scholar
Tran, E. et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science 344, 641–645 (2014).
Google Scholar
Garber, K. Pursuit of tumour-infiltrating lymphocyte immunotherapy speeds up. Nat. Biotechnol. 37, 969–971 (2019).
Google Scholar
Borch, T. H. et al. Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma. J. Immunother. Cancer 8, 1–7 (2020).
Kverneland, A. H. et al. Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer. Oncotarget 11, 2092–2105 (2020).
Google Scholar
Valpione, S. et al. Immune awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy. Nat. Cancer 1, 210–221 (2020).
Google Scholar
Guo, X. et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat. Med. 24, 978–985 (2018).
Google Scholar
Simoni, Y. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575–579 (2018).
Google Scholar
Duhen, T. et al. Co-expression of CD39 and CD103 identifies tumour-reactive CD8 T cells in human solid tumours. Nat. Commun. 9, 2724 (2018).
Google Scholar
Krishna, S. et al. Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer. Science 370, 1328–1334 (2020).
Google Scholar
Poschke, I. et al. A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma. Cancer Immunol. Immunother. 63, 1061–1071 (2014).
Google Scholar
Stevanović, S. et al. A phase II study of tumour-infiltrating lymphocyte therapy for human papillomavirus-associated epithelial cancers. Clin. Cancer Res. 25, 1486–1493 (2019).
Google Scholar
Mishra, A. et al. Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumour cells. Proc. Natl Acad. Sci. USA 117, 16839–16847 (2020).
Google Scholar
Individualized treatments for the many. Nat. Biomed. Eng. 3, 755–756 (2019).
Dong, M. B. et al. Systematic immunotherapy target discovery using genome-scale in vivo CRISPR screens in CD8 T cells. Cell 178, 1189–1204.e23 (2019).
Google Scholar
Hall, M. L. et al. Expansion of tumour-infiltrating lymphocytes (TIL) from human pancreatic tumours. J. Immunother. Cancer 4, 1–12 (2016).
Google Scholar
Garaud, S. et al. Tumour-infiltrating B cells signal functional humoral immune responses in breast cancer. JCI Insight 4, e129641 (2019).
Google Scholar
Wagner, P. et al. Detection and functional analysis of tumour infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer. Ann. Surg. Oncol. 15, 2310–2317 (2008).
Google Scholar
Salot, S. et al. Large scale expansion of Vγ9Vδ2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS ‘TCR γ/δ + T cell isolation kit’. J. Immunol. Methods 347, 12–18 (2009).
Google Scholar
Geens, M. et al. The efficiency of magnetic-activated cell sorting and fluorescence-activated cell sorting in the decontamination of testicular cell suspensions in cancer patients. Hum. Reprod. 22, 733–742 (2007).
Google Scholar
Faraghat, S. A. et al. High-throughput, low-loss, low-cost, and label-free cell separation using electrophysiology-activated cell enrichment. Proc. Natl Acad. Sci. USA 114, 4591–4596 (2017).
Google Scholar
Sutermaster, B. A. & Darling, E. M. Considerations for high-yield, high-throughput cell enrichment: fluorescence versus magnetic sorting. Sci. Rep. 9, 227 (2019).
Google Scholar
Mair, B. et al. High-throughput genome-wide phenotypic screening via immunomagnetic cell sorting. Nat. Biomed. Eng. 3, 796–805 (2019).
Google Scholar
Moore, D. K. et al. Isolation of B-cells using Miltenyi MACS bead isolation kits. PLoS ONE 14, e0213832 (2019).
Google Scholar
Witek, M. A., Freed, I. M. & Soper, S. A. Cell separations and sorting. Anal. Chem. 92, 105–131 (2020).
Google Scholar
Zhou, Y. et al. Evaluation of single-cell cytokine secretion and cell–cell interactions with a hierarchical loading microwell chip. Cell Rep. 31, 107574 (2020).
Google Scholar
Segaliny, A. I. et al. Functional TCR T cell screening using single-cell droplet microfluidics. Lab Chip 18, 3733–3749 (2018).
Google Scholar
Lin, E. et al. High-throughput microfluidic labyrinth for the label-free isolation of circulating tumour cells. Cell Syst. 5, 295–304.e4 (2017).
Google Scholar
Fachin, F. et al. Monolithic chip for high-throughput blood cell depletion to sort rare circulating tumour cells. Sci. Rep. 7, 10936 (2017).
Google Scholar
Zhao, W. et al. Tumour antigen-independent and cell size variation-inclusive enrichment of viable circulating tumour cells. Lab Chip 19, 1860–1876 (2019).
Google Scholar
Alix-Panabières, C. & Pantel, K. Challenges in circulating tumour cell research. Nat. Rev. Cancer 14, 623–631 (2014).
Google Scholar
Li, P. & Ai, Y. Label-free multivariate biophysical phenotyping-activated acoustic sorting at the single-cell level. Anal. Chem. 93, 4108–4117 (2021).
Google Scholar
Nawaz, A. A. et al. Acoustofluidic fluorescence activated cell sorter. Anal. Chem. 87, 12051–12058 (2015).
Google Scholar
Cheng, Z., Wu, X., Cheng, J. & Liu, P. Microfluidic fluorescence-activated cell sorting (μFACS) chip with integrated piezoelectric actuators for low-cost mammalian cell enrichment. Microfluid. Nanofluidics 21, 9 (2017).
Nie, X. et al. High-throughput dielectrophoretic cell sorting assisted by cell sliding on scalable electrode tracks made ofconducting-PDMS. Sens. Actuators B 327, 128873 (2021).
de Wijs, K. et al. Micro vapor bubble jet flow for safe and high-rate fluorescence-activated cell sorting. Lab Chip 17, 1287–1296 (2017).
Google Scholar
Jing, Y. et al. Negative selection of hematopoietic progenitor cells by continuous magnetophoresis. Exp. Hematol. 35, 662–672 (2007).
Google Scholar
Lin, S. et al. A flyover style microfluidic chip for highly purified magnetic cell separation. Biosens. Bioelectron. 129, 175–181 (2019).
Google Scholar
Murray, C. et al. Unsupervised capture and profiling of rare immune cells using multi-directional magnetic ratcheting. Lab Chip 18, 2396–2409 (2018).
Google Scholar
Wang, Z. et al. Ultrasensitive and rapid quantification of rare tumourigenic stem cells in hPSC-derived cardiomyocyte populations. Sci. Adv. 6, eaay7629 (2020).
Google Scholar
Labib, M. et al. Tracking the expression of therapeutic protein targets in rare cells by antibody-mediated nanoparticle labelling and magnetic sorting. Nat. Biomed. Eng. 5, 41–52 (2021).
Google Scholar
Mirzaei, H. R., Rodriguez, A., Shepphird, J., Brown, C. E. & Badie, B. Chimeric antigen receptors T cell therapy in solid tumour: challenges and clinical applications. Front. Immunol. 8, 1850 (2017).
Google Scholar
Ma, Q., Wang, Y., Lo, A. S. Y., Gomes, E. M. & Junghans, R. P. Cell density plays a critical role in ex vivo expansion of T cells for adoptive immunotherapy. J. Biomed. Biotechnol. 2010, 386545 (2010).
Google Scholar
Canale, F. P. et al. CD39 expression defines cell exhaustion in tumour-infiltrating CD8+ T cells. Cancer Res. 78, 115–128 (2018).
Google Scholar
Blank, C. U. et al. Defining ‘T cell exhaustion’. Nat. Rev. Immunol. 19, 665–674 (2019).
Google Scholar
Kortekaas, K. E. et al. CD39 identifies the CD4+ tumour-specific T-cell population in human cancer. Cancer Immunol. Res. 8, 1311–1321 (2020).
Google Scholar
Miller, B. C. et al. Subsets of exhausted CD8+ T cells differentially mediate tumour control and respond to checkpoint blockade. Nat. Immunol. 20, 326–336 (2019).
Google Scholar
Siddiqui, I. et al. Intratumoural Tcf1 + PD-1 + CD8 + T cells with stem-like properties promote tumour control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195–211.e10 (2019).
Google Scholar
Han, J. et al. Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy. Nat. Cancer 2, 300–311 (2021).
Google Scholar
Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550–1558 (2018).
Google Scholar
Carmona, S. J., Siddiqui, I., Bilous, M., Held, W. & Gfeller, D. Deciphering the transcriptomic landscape of tumour-infiltrating CD8 lymphocytes in B16 melanoma tumours with single-cell RNA-Seq. OncoImmunology 9, 1737369 (2020).
Google Scholar
Galletti, G. et al. Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans. Nat. Immunol. 21, 1552–1562 (2020).
Google Scholar
Im, S. J. et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417–421 (2016).
Google Scholar
Jansen, C. S. et al. An intra-tumoural niche maintains and differentiates stem-like CD8 T cells. Nature 576, 465–470 (2019).
Google Scholar
Held, W., Siddiqui, I., Schaeuble, K. & Speiser, D. E. Intratumoural CD8+ T cells with stem cell–like properties: implications for cancer immunotherapy. Sci. Transl. Med. 11, eaay6863 (2019).
Google Scholar
Chen, Z. et al. TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision. Immunity 51, 840–855.e5 (2019).
Google Scholar
Moesta, A. K., Li, X.-Y. & Smyth, M. J. Targeting CD39 in cancer. Nat. Rev. Immunol. 20, 739–755 (2020).
Google Scholar
Takenaka, M. C., Robson, S. & Quintana, F. J. Regulation of the T cell response by CD39. Trends Immunol. 37, 427–439 (2016).
Google Scholar
Nihei, O. K., de Carvalho, A. C. C., Savino, W. & Alves, L. A. Pharmacologic properties of P2Z/P2X7receptor characterized in murine dendritic cells: role on the induction of apoptosis. Blood 96, 996–1005 (2000).
Google Scholar
Perrot, I. et al. Blocking antibodies targeting the CD39/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies. Cell Rep. 27, 2411–2425.e9 (2019).
Google Scholar
Kuhny, M., Hochdörfer, T., Ayata, C. K., Idzko, M. & Huber, M. CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells. Cell Commun. Signal. 12, 40 (2014).
Google Scholar
Clarke, J. et al. Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer. J. Exp. Med. 216, 2128–2149 (2019).
Google Scholar
Bono, M. R., Fernández, D., Flores-Santibáñez, F., Rosemblatt, M. & Sauma, D. CD73 and CD39 ectonucleotidases in T cell differentiation: beyond immunosuppression. FEBS Lett. 589, 3454–3460 (2015).
Google Scholar
Ganesan, A.-P. et al. Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. Nat. Immunol. 18, 940–950 (2017).
Google Scholar
Pallett, L. J. et al. IL-2high tissue-resident T cells in the human liver: sentinels for hepatotropic infection. J. Exp. Med. 214, 1567–1580 (2017).
Google Scholar
Sun, X. et al. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/Entpd1 null mice. Hepatology 57, 205–216 (2013).
Google Scholar
Scholz, G. et al. Modulation of mTOR signalling triggers the formation of stem cell-like memory T cells. EBioMedicine 4, 50–61 (2016).
Google Scholar
Li, Q. et al. A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumour immunity. Immunity 34, 541–553 (2011).
Google Scholar
Biasco, L. et al. In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells. Sci. Transl. Med. 7, 273ra13 (2015).
Google Scholar
Rohaan, M. W., van den Berg, J. H., Kvistborg, P. & Haanen, J. B. A. G. Adoptive transfer of tumour-infiltrating lymphocytes in melanoma: a viable treatment option. J. Immunother. Cancer 6, 102 (2018).
Google Scholar
Seliktar-Ofir, S. et al. Selection of shared and neoantigen-reactive T cells for adoptive cell therapy based on CD137 separation. Front. Immunol. 8, 1211 (2017).
Google Scholar
Lee, H. J. et al. Expansion of tumour-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer. Oncotarget 8, 113345–113359 (2017).
Google Scholar
Hurtado, M. O. et al. Tumour infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function. PLoS ONE 14, e0216373 (2019).
Lindenberg, M. A. et al. Treatment with tumour-infiltrating lymphocytes in advanced melanoma: evaluation of early clinical implementation of an advanced therapy medicinal product. J. Immunother. 41, 413–425 (2018).
Google Scholar
Lindenberg, M. et al. Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness. BMC Cancer 20, 712 (2020).
Google Scholar
Lopes, A. G., Noel, R. & Sinclair, A. Cost analysis of vein-to-vein CAR T-cell therapy: automated manufacturing and supply chain. Cell Gene Ther. Insights 6, 487–510 (2020).
ten Ham, R. M. T. et al. What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings. Cytotherapy 22, 388–397 (2020).
Google Scholar
